Downstream process (DSP) development forPLEXARIS product is progressing by the Exopharm Manufacturing team based in Melbourne.
The Exopharm Manufacturing Team is getting bigger; extra staff and new manufacturing equipment to support manufacture of product for clinical trials and other experimentation.
Exosomes require sophisticated analytical approaches with new analytic instruments. which provided.
Expert & experience Exopharm Analytics Team have provided extensive information for inclusion in the PLEXOVAL study proposal.
All these steps are going to make EX1 leading company in this field, naturally SP will be reached at least $ level. "All In My Opinion"
EX1 Price at posting:
45.0¢ Sentiment: Buy Disclosure: Held
